Robert Busard Brown - Net Worth and Insider Trading
Robert Busard Brown Net Worth
The estimated net worth of Robert Busard Brown is at least $6,404 dollars as of 2024-05-02. Robert Busard Brown is the CEO of Fresh Tracks Therapeutics Inc and owns about 7,037 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $6,404. Details can be seen in Robert Busard Brown's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Busard Brown has not made any transactions after 2021-03-15 and currently still holds the listed stock(s).
Transaction Summary of Robert Busard Brown
Robert Busard Brown Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Busard Brown owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .
Click here to see the complete history of Robert Busard Brown’s form 4 insider trades.
Insider Ownership Summary of Robert Busard Brown
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-06-14 | director & Chief Executive Officer |
Robert Busard Brown Latest Holdings Summary
Robert Busard Brown currently owns a total of 1 stock. Robert Busard Brown owns 7,037 shares of Fresh Tracks Therapeutics Inc (FRTX) as of March 15, 2021, with a value of $6,404.
Latest Holdings of Robert Busard Brown
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-03-15 | 7,037 | 0.91 | 6,404 |
Holding Weightings of Robert Busard Brown
Robert Busard Brown Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Busard Brown has made a total of 1 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 2,222 shares on March 15, 2021, which cost Robert Busard Brown around $118,000.
Insider Trading History of Robert Busard Brown
- 1
Robert Busard Brown Trading Performance
GuruFocus tracks the stock performance after each of Robert Busard Brown's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Busard Brown is -27.94%. GuruFocus also compares Robert Busard Brown's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Busard Brown within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Busard Brown's insider trading performs compared to the benchmark.
Performance of Robert Busard Brown
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -29.41 | | | | | |
| Relative Return to S&P 500(%) | -34.49 | | | | | |
Robert Busard Brown Ownership Network
Robert Busard Brown Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Robert Busard Brown is the director & Chief Executive Officer of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Robert Busard Brown made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 210,807 shares, with a net purchase of 210,807 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 407,807 shares were bought by its insiders, resulting in a net purchase of 407,697 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Robert Busard Brown Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Busard Brown. You might contact Robert Busard Brown via mailing address: 5777 Central Avenue, Suite 102, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
